Carlo M Croce

21PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 08, 2026
MiR-155-driven loss of ICOSL and SOCS1 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion.

|Apr 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma.

|Apr 08, 2026
A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia.

Maria L Toribio, María J García-León, Marina García-Peydró

|Feb 19, 2026
What does BCL-2 do? From new molecular insights to the clinical implications.

Carlo M Croce, Stephen W G Tait, Ana J Garcia-Sáez

|Jan 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

Silvia Sabbioni, Paola Guerriero, Ram C Shankaraiah

|Aug 25, 2025
Loss of ICOSL expression in the progression to cervical carcinoma.

Gerard J Nuovo, Esmerina Tili, Carlo M Croce

Pageof 4

Frequent Collaborators

3 joint publications

Gian Luca Rampioni Vinciguerra

2 joint publications

Marina Capece

2 joint publications

Giovanni Nigita

1 joint publications

Koshi Mimori